北京大学学报(医学版) ›› 2017, Vol. 49 ›› Issue (4): 597-602. doi: 10.3969/j.issn.1671-167X.2017.04.008

• 论著 • 上一篇    下一篇

肾癌根治性切除加癌栓取出术治疗Mayo Ⅲ级下腔静脉癌栓的手术技术及临床经验

刘茁,马潞林△,田晓军,王国良,侯小飞,张树栋,邓绍晖   

  1. (北京大学第三医院泌尿外科, 北京100191)
  • 出版日期:2017-08-18 发布日期:2017-08-18
  • 通讯作者: 马潞林 E-mail: malulin@medmail.com.cn

Radical nephrectomy and thrombectomy for Mayo clinic stage Ⅲ tumor thrombus: a surgical technique and clinical experience

LIU Zhuo, MA Lu-lin△, TIAN Xiao-jun, WANG Guo-liang, HOU Xiao-fei, ZHANG Shu-dong, DENG Shao-hui   

  1. (Department of Urology, Peking University Third Hospital, Beijing 100191, China)
  • Online:2017-08-18 Published:2017-08-18
  • Contact: MA Lu-lin E-mail: malulin@medmail.com.cn

摘要: 目的:探讨肾癌根治性切除加下腔静脉癌栓取出术治疗Mayo Ⅲ级下腔静脉癌栓(inferior vena cava tumor thrombus,IVCTT)的有效性和安全性,总结手术技术及临床经验。方法:回顾性分析2014年10月至2016年9月北京大学第三医院泌尿外科收治的8例肾癌合并Mayo Ⅲ级(美国Mayo医学中心分级法)IVCTT患者的临床资料。8例患者中男性3例,女性5例,年龄18~77岁,平均(58.0±18.7)岁,体重指数(body mass index,BMI)为15.2~30.8 kg/m2,平均(22.7±4.4) kg/m2。8例患者的肿瘤均位于右侧,肿瘤直径(7.9±2.5) cm。行开放肾癌根治性切除加下腔静脉癌栓取出术者5例,行腹腔镜下肾癌根治性切除加下腔静脉癌栓取出术者3例,其中1例患者行中转开放手术。结果:8例患者手术均顺利完成,无围术期死亡病例。手术时间272~567 min,平均(370.3±101.6) min。下腔静脉阻断时间17~55 min,平均(41.0±12.1) min。术中出血量200~3 000 mL,平均(1 181.3±915.7) mL。术中输注悬浮红细胞者5例,输入量800~2 000 mL,平均(850.0±783.8) mL。术中输注血浆者3例,输入量400~1 000 mL。术后住院时间9~23 d,平均(14.1±4.0) d。8例患者中4例因术中发现癌栓侵犯下腔静脉壁而行下腔静脉壁切除术。8例患者术前血肌酐值60~101 μmol/L,平均(76.4±15.3) μmol/L,术后1周血肌酐值74~127 μmol/L,平均(100.8±21.1) μmol/L。术后组织病理检查诊断为肾透明细胞癌(renal clear cell carcinoma,RCC)6例,肾乳头状腺癌(papillary adenocarcinoma)1例,Fuhrman分级为Ⅲ级6例、Ⅳ级1例,尤文肉瘤(Ewing’s sarcoma)1例。8例患者中,5例发生术后早期并发症,均为ClavienⅡ级并发症,未见严重并发症发生。8例患者均获随访,随访时间2~24个月,平均11.3个月。术前未发现远处转移的7例患者中,出现远处转移1例,为肺转移。结论:肾癌根治性切除加下腔静脉癌栓取出术治疗Mayo Ⅲ级下腔静脉癌栓较为有效、安全。Ⅲ级静脉癌栓延伸范围广,手术技术难度较大,充分的术前准备、丰富的解剖学知识和手术操作经验可提高手术安全性。

关键词:  肾肿瘤, 癌栓, 腔静脉,

Abstract: Objective: To evaluate the effectiveness and safety of radical nephrectomy and inferior vena cava thrombectomy in the treatment of patients with Mayo Ⅲ tumor thrombus, and to introduce our experience and surgical technique. Methods: The clinical data of 8 patients with Mayo Ⅲ tumor thrombus from October 2014 to September 2016 were analyzed retrospectively. Of the 8 patients, 3 were male and 5 were female. The average age was (50.8±18.7) years (18 to 77 years). The average body mass index (BMI) was (22.7±4.4) kg/m2 (15.2 to 30.8 kg/m2). Imaging suggested the right renal tumor in all the 8 cases. The average tumor size was (7.9±2.5) cm. Open radical nephrectomy and inferior vena cava thrombectomy was conducted in 5 cases and laparoscopic surgery in 3 cases, and 1 case was converted to open surgery. Results: All the 8 surgeries were completed successfully with no death case. The average surgery time was (370.3±101.6) min, ranging from 272-567 min. The average vena cava blocked time was (41.0±12.1) min, ranging from 17-55 min. The blood loss volume was (1 181.3±915.7) mL, ranging from 200-3 000 mL. During the operation, 5 cases were infused with suspended red blood cells, the amount of blood transfusion was 800-2 000 mL. 3 cases were infused of plasma with 400-1 000 mL. The average hospital stay was 9-23 d, with an average of (14.1±4.0) d. In the 8 patients, 4 cases underwent inferior vena cava wall resection because of invasion by tumor thrombus. Preoperative serum creatinine was 60-101 μmol/L, with an average of (76.4±15.3) μmol/L. Serum creatinine 1 week after the operation was 74-127 μmol/L, with an average of (100.8±21.1) μmol/L. Pathological diagnosis showed 6 cases of clear cell carcinoma, 1 case of papillary carcinoma type Ⅱ, and 1 case of Ewing’s sarcoma. Among the 8 patients, early postoperative complications occurred in 5 cases. Postoperative complications were graded as level Ⅱ, according to the Clavien classifications. The 8 cases were followed up for 2 to 24 months with an average of 11.3 months. There was 1 patient who suffered from lung metastasis. Conclusion: Our initial clinical results show that radical nephrectomy and inferior vena cava thrombectomy is safe and effective for patients with Mayo Ⅲ tumor thrombus. The wide extension of grade Ⅲ vein tumor thrombus leads to the difficulty of operation technique. Sufficient preoperative preparation, rich operative experience and skills can improve the safety of operation.

Key words: Kidney neoplasms, Tumor thrombus, Vena cava, inferior

中图分类号: 

  • R737.11
[1] 张树栋,谢睿扬. 机器人手术时代的肾癌合并腔静脉瘤栓治疗策略[J]. 北京大学学报(医学版), 2024, 56(4): 562-564.
[2] 李雨清,王飚,乔鹏,王玮,关星. 经耻骨后尿道中段悬吊带术治疗女性复发性压力性尿失禁的中长期疗效[J]. 北京大学学报(医学版), 2024, 56(4): 600-604.
[3] 刘帅,刘磊,刘茁,张帆,马潞林,田晓军,侯小飞,王国良,赵磊,张树栋. 伴静脉癌栓的肾上腺皮质癌的临床治疗及预后[J]. 北京大学学报(医学版), 2024, 56(4): 624-630.
[4] 李红光,韩玮华,吴训,冯继玲,李刚,孟娟红. 关节腔冲洗联合液态浓缩生长因子注射治疗单侧颞下颌关节骨关节炎的初步研究[J]. 北京大学学报(医学版), 2024, 56(2): 338-344.
[5] 陈晓颖,张一,李雨柯,唐琳,刘玉华. 不同种类聚合物对猪小肠黏膜下层支架仿生矿化的影响[J]. 北京大学学报(医学版), 2024, 56(1): 17-24.
[6] 徐心雨,吴灵,宋凤岐,李自力,张益,刘筱菁. 基于下颌运动轨迹的正颌外科术中下颌骨髁突定位方法及初步精度验证[J]. 北京大学学报(医学版), 2024, 56(1): 57-65.
[7] 王聪伟,高敏,于尧,章文博,彭歆. 游离腓骨瓣修复下颌骨缺损术后义齿修复的临床分析[J]. 北京大学学报(医学版), 2024, 56(1): 66-73.
[8] 兰东,刘茁,李宇轩,王国良,田晓军,马潞林,张树栋,张洪宪. 根治性肾切除和静脉癌栓取出术大出血的危险因素[J]. 北京大学学报(医学版), 2023, 55(5): 825-832.
[9] 汪大伟,王华东,李利,尹欣,黄伟,郭继东,杨亚锋,刘义灏,郑扬. 自体下关节突骨块应用于骨质疏松患者腰椎椎间融合术的疗效分析[J]. 北京大学学报(医学版), 2023, 55(5): 899-909.
[10] 卢汉,张建运,杨榕,徐乐,李庆祥,郭玉兴,郭传瑸. 下颌牙龈鳞状细胞癌患者预后的影响因素[J]. 北京大学学报(医学版), 2023, 55(4): 702-707.
[11] 侯卫华,宋书杰,石中月,金木兰. 幽门螺杆菌阴性早期胃癌的临床病理特征[J]. 北京大学学报(医学版), 2023, 55(2): 292-298.
[12] 刘菊梅,梁丽,张继新,戎龙,张梓怡,吴悠,赵旭东,李挺. 411例早期胃癌及癌前病变内镜黏膜下剥离术标本的病理学评估[J]. 北京大学学报(医学版), 2023, 55(2): 299-307.
[13] 周华,王仁吉,刘忠军,刘晓光,吴奉梁,党礌,韦峰. 3D打印人工椎体在颈椎脊索瘤全脊椎切除术中的应用[J]. 北京大学学报(医学版), 2023, 55(1): 144-148.
[14] 高梓翔,王勇,温奥楠,朱玉佳,秦庆钊,张昀,王晶,赵一姣. 基于三维下颌骨平均模型的颌骨标志点自动确定方法[J]. 北京大学学报(医学版), 2023, 55(1): 174-180.
[15] 李雨柯,王梅,唐琳,刘玉华,陈晓颖. 不同pH值对脱细胞小肠黏膜下层海绵支架螯合锶离子的影响[J]. 北京大学学报(医学版), 2023, 55(1): 44-51.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!